Oral Ondansetron Administration in Emergency Departments to Children with Gastroenteritis: An Economic Analysis

English version České info

Background:
The use of antiemetics for children with vomiting is one of the most controversial decisions in the treatment of gastroenteritis in developed countries. Ondansetron, a selective serotonin receptor antagonist, has been found to be effective in improving the success of oral rehydration therapy. However, North American and European clinical practice guidelines continue to recommend against its use, stating that evidence of cost savings would be required to support ondansetron administration. Thus, an economic analysis of the emergency department administration of ondansetron was conducted. The primary objective was to conduct a cost analysis of the routine administration of ondansetron in both the United States and Canada.

Methods and Findings:
A cost analysis evaluated oral ondansetron administration to children presenting to emergency departments with vomiting and dehydration secondary to gastroenteritis from a societal and health care payer's perspective in both the US and Canada. A decision tree was developed that incorporated the frequency of vomiting, intravenous insertion, hospitalization, and emergency department revisits. Estimates of the monetary costs associated with ondansetron use, intravenous rehydration, and hospitalization were derived from administrative databases or emergency department use. The economic burden in children administered ondansetron plus oral rehydration therapy was compared to those not administered ondansetron employing deterministic and probabilistic simulations. We estimated the costs or savings to society and health care payers associated with the routine administration of ondansetron. Sensitivity analyses considered variations in costs, treatment effects, and exchange rates. In the US the administration of ondansetron to eligible children would prevent approximately 29,246 intravenous insertions and 7,220 hospitalizations annually. At the current average wholesale price, its routine administration to eligible children would annually save society US$65.6 million (US$49.1–US$81.1) and health care payers US$61.1 million (US$46.2–US$76.3). In Canada the administration of ondansetron to eligible children would prevent 4,065 intravenous insertions and 1,003 hospitalizations annually. Its routine administration would annually save society CDN$1.72 million (CDN$1.15–CDN$1.89) and the health care system CDN$1.18 million (CDN$0.88–CDN$1.41).

Conclusions:
In countries where intravenous rehydration is often employed, the emergency department administration of oral ondansetron to children with dehydration and vomiting secondary to gastroenteritis results in significant monetary savings compared to a no-ondansetron policy.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Oral Ondansetron Administration in Emergency Departments to Children with Gastroenteritis: An Economic Analysis. PLoS Med 7(10): e32767. doi:10.1371/journal.pmed.1000350
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000350

Souhrn

Zdroje

1. GuarinoA

AlbanoF

AshkenaziS

GendrelD

HoekstraJH

2008 European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary. J Pediatr Gastroenterol Nutr 46 619 621

2. KingCK

GlassR

BreseeJS

DugganC

2003 Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 52 1 16

3. ReisEC

GoeppJG

KatzS

SantoshamM

1994 Barriers to use of oral rehydration therapy. Pediatrics 93 708 711

4. OzuahPO

AvnerJR

SteinRE

2002 Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics 109 259 261

5. LiST

DiGiuseppeDL

ChristakisDA

2003 Antiemetic use for acute gastroenteritis in children. Arch Pediatr Adolesc Med 157 475 479

6. KwonKT

RudkinSE

LangdorfMI

2002 Antiemetic use in pediatric gastroenteritis: a national survey of emergency physicians, pediatricians, and pediatric emergency physicians. Clin Pediatr (Phila) 41 641 652

7. StarkePR

WeaverJ

ChowdhuryBA

2005 Boxed warning added to promethazine labeling for pediatric use. N Engl J Med 352 2653

8. FreedmanSB

AdlerM

SeshadriR

PowellEC

2006 Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med 354 1698 1705

9. RamsookC

Sahagun-CarreonI

KozinetzCA

Moro-SutherlandD

2002 A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med 39 397 403

10. RoslundG

HeppsTS

McQuillenKK

2008 The role of oral ondansetron in children with vomiting as a result of acute gastritis/gastroenteritis who have failed oral rehydration therapy: a randomized controlled trial. Ann Emerg Med 52 22 29 e26

11. StorkCM

BrownKM

ReillyTH

SecretiL

BrownLH

2006 Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children. Acad Emerg Med 13 1027 1033

12. ReevesJJ

ShannonMW

FleisherGR

2002 Ondansetron decreases vomiting associated with acute gastroenteritis: a randomized, controlled trial. Pediatrics 109 e62

13. CubedduLX

TrujilloLM

TalmaciuI

GonzalezV

GuariguataJ

1997 Antiemetic activity of ondansetron in acute gastroenteritis. Aliment Pharmacol Ther 11 185 191

14. DeCampLR

ByerleyJS

DoshiN

SteinerMJ

2008 Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis. Arch Pediatr Adolesc Med 162 858 865

15. National Collaborating Centre for Women's and Children's Health Diarrhoea and vomiting caused by gastroenteritis: diagnosis, assessment and management in children younger than 5 years London National Institute for Health and Clinical Excellence

16. SzajewskaH

Gieruszczak-BialekD

DylagM

2007 Meta-analysis: ondansetron for vomiting in acute gastroenteritis in children. Aliment Pharmacol Ther 25 393 400

17. AlhashimiD

Al-HashimiH

FedorowiczZ

2009 Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev CD005506

18. DrummondMF

JeffersonTO

1996 Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 313 275 283

19. Statistics Canada. Age and sex, 2006 count for both sexes, for Canada, provinces and territories - 100% data. Available at: http://www12.statcan.gc.ca/census-recensement/2006/dp-pd/tbt/Rp-eng.cfm?LANG=E&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=1&PID=88977&PRID=0&PTYPE=88971,97154&S=0&SHOWALL=0&SUB=0&Temporal=2006&THEME=66&VID=0&VNAMEE=&VNAMEF=. Accessed 15 November 2008

20. TiederJS

RobertsonA

GarrisonMM

2009 Pediatric hospital adherence to the standard of care for acute gastroenteritis. Pediatrics 124 e1081 1087

21. AvendanoP

MatsonDO

LongJ

WhitneyS

MatsonCC

1993 Costs associated with office visits for diarrhea in infants and toddlers. Pediatric Infectious Disease Journal 12 897 902

22. FersonMJ

StringfellowS

McPhieK

McIverCJ

SimosA

1997 Longitudinal study of rotavirus infection in child-care centres. Journal of Paediatrics & Child Health 33 157 160

23. CoffinSE

ElserJ

MarchantC

SawyerM

PollaraB

2006 Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States. Pediatric Infectious Disease Journal 25 584 589

24. HardyAM

LairsonDR

MorrowAL

1994 Costs associated with gastrointestinal-tract illness among children attending day-care centers in Houston, Texas. Pediatrics 94 1091 1093

25. HuninkM

GlasziouP

SiegelJ

WeeksJ

PliskinJ

2001 Decision making in health and medicine Cambridge Cambridge University Press

26. U.S. Department of Labor, Bureau of Labor Statistics. Available: www.bls.gov/cpid07av.pdf. Accessed 7 June 2010

27. U.S. Department of Labor, Bureau of Labor Statistics. Available: www.bls.gov/cpid08av.pdf. Accessed 7 June 2010

28. Statistics Canada. Consumer Price Index, health and personal care, by province. Available: www40.statcan.gc.ca/l01/cst01/econ161a-eng.htm. Accessed 16 September 2010

29. Physicians desk reference editorial staff 2008 Red book: pharmacy's fundamental reference. 110th edition Montvale (New Jersey) Thomson Healthcare

30. TunisSL

2009 A cost-effectiveness analysis to illustrate the impact of cost definitions on results, interpretations and comparability of pharmacoeconomic studies in the US. Pharmacoeconomics 27 735 744

31. ChangP

OkamotoM

ChenJ

FrameD

2005 Cost-effectiveness analysis of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting. J Manag Care Pharm 11 317 321

32. Yale WassermanDMD

2008 Physicians' fee reference 2008. 25th edition Milwaukee (Wisconsin) Medical Publishers, Ltd

33. YeeEL

StaatMA

AzimiP

BernsteinDI

WardRL

2008 Burden of rotavirus disease among children visiting pediatric emergency departments in Cincinnati, Ohio, and Oakland, California, in 1999–2000. Pediatrics 122 971 977

34. US Bureau of Labor and Statistics 2006 National Compensation Survey, June 2006. Available: http://www.bls.gov/NCS/. Accessed 7 November 2008

35. CANSIM database Table 281-0030 2010 Average hourly earning for employees paid by the hour (SEPH), unadjusted for seasonal variation for selected industries classified using the North American Industry Classification System (NAICS), annual (dollars). Available: http://cansim2.statcan.ca/cgi-win/cnsmcgi.exe?Lang=E&RootDir=CII/&ResultTemplate=CII/CII_pick&Array_Pick=1&ArrayId=281-0030

36. CarrollAE

DownsSM

2009 Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr 155 21 25

37. Committee on Infectious D, American Academy of P 2009 Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics 123 1412 1420

38. WiddowsonMA

MeltzerMI

ZhangX

BreseeJS

ParasharUD

2007 Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 119 684 697

39. WHO/UNICEF 2004 Joint statement: clinical management of acute diarrhoea (WHO/FCH/CAH/04.07) Geneva and New York World Health Organization, Department of Child and Adolescent Health and Development, and United Nations Children's Fund, Programme Division

40. WalkerCL

BlackRE

2010 Zinc for the treatment of diarrhoea: effect on diarrhoea morbidity, mortality and incidence of future episodes. Int J Epidemiol 39 Suppl 1 i63 i69

41. SturmJJ

HirshDA

SchweickertA

MasseyR

SimonHK

2009 Ondansetron use in the pediatric emergency department and effects on hospitalization and return rates: are we masking alternative diagnoses? Ann Emerg Med 55 415 422

42. GavaganT

SchumannSA

2009 This antiemetic may help kids skip that trip to the hospital. J Fam Pract 58 85 88

43. PasrichaPJ

2006 Treatment of disorders of bowel motility and water flux; antiemetics; agents used in biliary and pancreatic disease.

BruntonLL

LazoJS

ParkerKL

Goodman & Gilman's the pharmacological basis of therapeutics New York McGraw-Hill Companies, Inc 983 1008

44. GenerB

BurnsJM

GriffinS